S

Shenzhen Salubris Pharmaceuticals Co Ltd
SZSE:002294

Watchlist Manager
Shenzhen Salubris Pharmaceuticals Co Ltd
SZSE:002294
Watchlist
Price: 31.71 CNY -1.74%
Market Cap: 35.4B CNY
Have any thoughts about
Shenzhen Salubris Pharmaceuticals Co Ltd?
Write Note

Shenzhen Salubris Pharmaceuticals Co Ltd
Investor Relations

Shenzhen Salubris Pharmaceuticals Co., Ltd. stands as a dynamic player in the pharmaceutical landscape, tracing its origins to China’s bustling hub of innovation, Shenzhen. From its inception, Salubris has steadily cultivated a robust portfolio, deeply rooted in the development, production, and commercialization of a wide array of pharmaceutical products. With a steadfast focus on cardiovascular and cerebrovascular medications, the company has adeptly positioned itself to meet significant medical needs, leveraging its expertise to produce both traditional and novel therapies. This focus is complemented by an ambitious expansion into biopharmaceuticals, a sector that holds significant potential for growth. Salubris thrives by combining its innovative R&D capabilities with efficient production processes, ensuring that its offerings not only reach a broad customer base but also adhere to stringent quality standards.

The company’s business model revolves around a meticulously crafted combination of research innovation and strategic partnerships. By investing significantly in research and development, Salubris ensures a pipeline filled with promising drugs poised to address prevalent health issues. The company maximizes its revenues through its sales network, which extends beyond domestic borders, tapping into international markets where demand for high-quality pharmaceuticals continues to rise. Additionally, Salubris has been proactive in pursuing collaborations and partnerships, both to bolster its research capabilities and to navigate regulatory landscapes more effectively. By marrying these strategic approaches, Salubris not only sustains its competitive edge but also ensures a steady growth trajectory, embodying a business narrative that resonates with resilience and forward-thinking ambition.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Jie Yan
GM & Director
No Bio Available
Ms. Yun Kong CPA
CFO, Accounting Supervisor & Financial Manager
No Bio Available
Mr. Jianfeng Yang
Secretary of the Board of Directors & Non Independent Director
No Bio Available
Ms. Song Ping Zhao
Deputy General Manager
No Bio Available
Dr. Xie Heng M.D., Ph.D.
Chief Medical Officer
No Bio Available

Contacts

Address
GUANGDONG
Shenzhen
37F, Main Building, NEO Square, Chegong Temple, No.6009 Shennan Avenue, Futian District
Contacts
+8675583867888
www.salubris.cn